1 / 37

Incidentolomas - Evaluation and Management of Incidental Liver Lesions

Incidentolomas - Evaluation and Management of Incidental Liver Lesions. Patrick M. Horne, MSN, ARNP, FNP-BC Assistant Director of Hepatology Clinical Research Division of Gastroenterology, Hepatology and Nutrition University of Florida Health. Disclosures.

moses
Download Presentation

Incidentolomas - Evaluation and Management of Incidental Liver Lesions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Incidentolomas - Evaluation and Management of Incidental Liver Lesions Patrick M. Horne, MSN, ARNP, FNP-BC Assistant Director of Hepatology Clinical Research Division of Gastroenterology, Hepatology and Nutrition University of Florida Health

  2. Disclosures • Financial relationships to disclose within the past 12 months: • Grant support with Bayer/Onyx

  3. Objectives • Discuss natural history of benign liver lesions. • Discuss Evaluation and management of FNH, Hemangioma, Liver Cyst, Adenoma

  4. Background • Causes of focal liver lesions are diverse and can range widely. • Typically are clinically silent and detected incidentally while undergoing evaluation for unrelated symptoms. • Understanding the clinical circumstances surrounding the presence of liver lesions aids in better diagnosis.

  5. Differential diagnosis • Common benign liver lesions include: • Hepatic hemangioma • Focal nodular hyperplasia (FNH) • Hepatic adenoma • Hepatic cyst • Idiopathic noncirrhotic portal hypertension • Focal nodular hyperplasia • Regenerative nodules Bonder A & Afdhal N. Clin. Liver Dis. 2012

  6. Case 1 • 40 year old Caucasian female presents to her PCP’s office intermittent nonspecific abdominal pain and nausea. • Physical exam negative but abdominal ultrasound ordered which notes a possible lesion. • Follow up imaging obtained

  7. Case 1 Persistent enhancement throughout imaging phases

  8. Hemangioma • Most common benign hepatic tumor • 60-80% diagnosed in people between the ages of 30-50. • Ratio of occurrence in women to men, 3:1. • More common in young women Choi BY & Nguyen MH. J ClinGastroenterol. 2005

  9. Hemangioma-Diagnosis • On ultrasound appear well-defined, lobulated, homogeneous hyperechoicmass. • The accuracy of US is reported to be 70% to 80%. • CT and/or MRI was best options • With MRI having sensitivity and specificity around 85-95%. DescottesBet al. Surg. Endosc. 2003. Unai O et al. Clin Imaging. 2002.

  10. Hemangioma-Management • Treatment is usually not indicated in the setting of no symptoms with a firm diagnosis and confirmed stability on imaging at least 6 months apart. • Lesions less than 5 cm • Larger lesions may require closer monitoring and if symptoms develop may need to treatment. Blecker E et al. Z. Gastroenterol. 2003

  11. Hemangioma-Management • Treatment options include • Surgery • Resection • Hepatic irradiation or transarterial catheter chemoembolization

  12. Case 2 • 25 year old Hispanic female undergoing work up for elevated liver function tests (LFTs). • Noted to have multiple liver lesions on abdominal ultrasound, the largest measuring 13 cm in diameter. • Follow up imaging including CT and MRI completed.

  13. CT scan Case 2-Imaging

  14. Case 2-Imaging • MRI

  15. Focal Nodular Hyperplasia (FNH) • Second most common liver tumor • Incidence is on the rise due to better imaging. • Can occur in both men and women • 80-95% of cases seen in women, ratio 5:1 Bartolotta TV et al. La RadiologiaMedica. 2013.

  16. FNH-features • Class findings include: • Presence of a “central scar” on contrast enhanced imaging • Present in about 1/3 of patients • Lesions typically become hyperdense during arterial phase imaging. • Due to arterial origin of the blood supply • Isodense during portal venous phase • Though central scar may be hyperdense Bartolotta TV et al. La RadiologiaMedica. 2013.

  17. FNH-Diagnosis • Sulfur colloid scanning • Due to prevalence of Kupffer cells, 80% of FNHs will show active uptake

  18. FNH-Management • Typically conservative. • Typically stable lesions and do not change over time • No evidence to suggest malignant transformation • Enlargement and/or development in the setting of OCP?

  19. Case 3 • 30 year old Caucasian female presents with chronic abdominal pain. • Has been on oral contraception therapy for 5 years • Otherwise healthy, no significant medical history.

  20. Case 3 MRI

  21. Hepatic adenoma • Uncommon lesions • Mostly in young women (22-40) • Commonly in the right lobe of the liver Grazioli L. Radiographics. 2001

  22. Hepatic adenoma • Strong association with: • Oral contraceptives and hormones • Anabolic steroids • Glycogen storage disease • Less common association: • Pregnancy • Diabetes mellitus

  23. Farges O. Gut. 2011

  24. Hepatic adenoma • Prognosis not well established • There is an association with: • Malignant transformation • Spontaneous hemorrhage • Rupture

  25. Hepatic adenoma-Diagnosis • Typically made clinically with imaging. • Biopsy of the lesion is not indicated or recommended due to risk of bleeding. • Imaging techniques: • US-limited • CT and/or MRI

  26. Hepatic adenoma-Diagnosis • CT: Well demarcated and have low attenuation or are isodense on noncontrast imaging and show peripheral enhancement early with centipedal flow during portal venous. • MRI: usually well demarcated and typically hyperintense on T1. Enhancement on T2 images that enhance further with gadolinium administration is highly suggestive. Grazioli L. Radiographics. 2001 Chung. KY AJR. 1995

  27. Hepatic adenoma-Management • Dependent on size of lesion and symptoms • If asymptomatic and lesion is small (less than 5 cm) • Stop OCP if taking • Can monitor with imaging and possibly AFP • If symptomatic and/or lesion is large (greater than 5 cm) • Surgical resection is recommended. • Liver transplantation rare Dokmak S. et al. Gastroenterology. 2009

  28. Case 4 • 60 year old female presents to a local ER with severe abdominal pain with a palpable mass on physical examination. • No known history of liver disease or GI symptoms

  29. Case 4

  30. Hepatic cyst-Differential

  31. Hepatic cyst-Prevalence • Dependent on origin • Simple: • More common in right lobe. • More in women, ratio of 1.5:1. • Distinction between simple and other types of cysts is difficult to make but very important for management. • Huge cysts found often in women over age 50.

  32. Hepatic cyst-Diagnosis • Ultrasound: • Good at distinguishing between simple and other cystic lesions • CT scan: • Well demarcated lesion with no enhancement after administration of IV contrast. • MRI: • No enhancement with contrast. T1-weighted images the cyst shows a low signal, whereas a very high intensity signal is shown on T2-weighted images.

  33. Lantinga MA. 2013. World Journal of Gastro.

  34. Hepatic cyst-Management • Symptoms and type of cyst drive the management • Majority do not require intervention (if simple). • Would consider monitoring large cysts over 4 cm with interval imaging. • Minor and major surgical options available for large cysts and/or symptoms

  35. Hepatic cyst-Management • Interventions: • Needle aspiration (though associated with high failure rate and rapid recurrence) • Deroofing • Liver resection • If infectious, treat appropriately. Yasawry MI. World J Gastroenterol. 2011

  36. Conclusion • Liver lesions are common and proper diagnosis is important. • A combination of medical history as well as appropriate imaging is essential. • Most liver lesions are benign but in certain situations must be addressed or treated.

  37. Thank you

More Related